Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29012208 | 0.95 | CHEK1 (0.49) | CHEK1CDK2AP1 | |
| SCHEMBL29012210 | 0.85 | CHEK1 (0.41) | CHEK1 | |
| SCHEMBL29012233 | 0.84 | CHEK1 (0.40) | CHEK1 | |
| SCHEMBL12948509 | 0.84 | CHEK1 (0.56) | CHEK1CDK2AP1 | |
| SCHEMBL29012252 | 0.84 | CHEK1 (0.40) | CHEK1 | |
| SCHEMBL8835672 | 0.83 | CHEK1 (0.54) | CHEK1CDK2AP1 | |
| SCHEMBL4343133 | 0.83 | CHEK1 (0.68) | CHEK1CDK2AP1 | |
| SCHEMBL29900120 | 0.83 | CHEK1 (0.68) | CHEK1CDK2AP1 | |
| SCHEMBL29900038 | 0.83 | CHEK1 (0.68) | CHEK1CDK2AP1 | |
| SCHEMBL27768326 | 0.83 | CHEK1 (0.68) | CHEK1CDK2AP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115038439-A | Combination cancer therapy with CHK inhibitors | 上海华禹生物科技有限公司 | 2022-09-09 | — | — | CN | claimed |
| CN-115038440-A | Combination cancer therapy with CHK inhibitors | 上海华禹生物科技有限公司 | 2022-09-09 | — | — | CN | claimed |
| CN-115038439-A | Combination cancer therapy with CHK inhibitors | 上海华禹生物科技有限公司 | 2022-09-09 | — | — | CN | disclosed |
| CN-115038440-A | Combination cancer therapy with CHK inhibitors | 上海华禹生物科技有限公司 | 2022-09-09 | — | — | CN | disclosed |